News | April 19, 2007

Cedars-Sinai’s Dr. John Harold Receives AHA “Passion of the Heart” Award

April 20, 2007 — John G. Harold, M.D., a cardiologist at Cedars-Sinai Medical Center, was presented with the “Passion of the Heart” award at the annual Heart Awards Gala on April 14, hosted by the American Heart Association’s Western States Affiliate. The “Passion of the Heart” award is the highest recognition of a physician by the organization.

Dr. Harold, who joined Cedars-Sinai’s medical staff in 1985, recently served as chief of staff, one of several leadership positions he has held at the medical center.

He is currently president of the California Chapter of the American College of Cardiology (ACC) and as ACC governor for Southern California. He is also a board member of organizations such as the American Heart Association, the American Board of Internal Medicine, Save A Heart Foundation, the Heart Fund at Cedars-Sinai, and UCLA’s Clinical Faculty Association.

The first-generation son of Irish immigrants, Harold was born in California but grew up in the Bronx, New York, receiving his medical degree from the State University of New York at Stony Brook. After completing his internal medicine training at Mount Sinai Hospital in New York City, he came to Cedars-Sinai in 1982 to complete a three-year cardiology fellowship under the direction of his mentor, Jeremy Swan, M.D., chairman of the Division of Cardiology from 1965 to 1987.

Dr. Harold received the award from Prediman K. Shah, M.D., director of the Division of Cardiology and the Atherosclerosis Research Center at Cedars-Sinai, and Asher Kimchi, M.D., a Cedars-Sinai cardiologist who was the recipient of last year’s “Passion” award. Both presenters are honorary medical chairs of the event and Shah currently serves as president of the Western States Affiliate.

In addition to recognizing outstanding service, the gala raises funds to help end heart disease and stroke, contributing to the research, education and advocacy responsible for saving thousands of lives across the country.

For more information visit

Related Content

Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Robotic-Assisted PCI With CorPath GRX Broadcast Live at TCT Asia-Pacific Summit
News | Robotic Systems| May 01, 2017
Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems| April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath GRX System
News | Robotic Systems| April 12, 2017
Corindus Vascular Robotics Inc. announced that the first robotic-assisted percutaneous coronary intervention (PCI)...
Stereotaxis, Niobe remote magnetic navigation system, Philips Allura Xper FD10 cardiovascular X-ray, interface, integration
News | Robotic Systems| January 20, 2017
Stereotaxis Inc. announced the release of an interface between its remote magnetic navigation system for...
Sponsored Content | Videos | Robotic Systems| November 22, 2016
Corindus Vascular Robotics received U.S.
Corindus, Corpath, robotic navigation, Robotic PCI, CorPath GRX
Technology | October 27, 2016
October 27, 2016 — Corindus Vascular Robotics Inc. announced it received 510(k) clearance from the U.S.
Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures
News | Robotic Systems| October 25, 2016
Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed...
bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Overlay Init